Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer

Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer

Background: Recent data suggest that human epidermal growth factor receptor 2 (HER2)-low breast cancer may represent a distinct entity. We aimed to compare disease characteristics and outcomes between HER2-low and HER2-0 in estrogen receptor (ER) positive, early-stage breast cancer. Methods: A singl...

Full description

Bibliographic Details
Main Authors: Raz Mutai, Tamar Barkan, Assaf Moore, Michal Sarfaty, Tzippy Shochat, Rinat Yerushalmi, Salomon M. Stemmer, Hadar Goldvaser
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Breast
Subjects:
Breast cancer
HER2-Low
Oncotype DX RS
Genomic risk
Prognosis
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621004367

Internet

http://www.sciencedirect.com/science/article/pii/S0960977621004367

Similar Items